BMI of 30 or higher (obesity) BMI of 27 or higher with at least one weight-related condition (hypertension, high cholesterol, sleep apnea, Type 2 diabetes, or cardiovascular disease) Prior difficulty maintaining weight loss through diet and exercise alone No contraindicated medical history (reviewed at consultation) Commitment to regular monitoring and follow-up visits Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Prior serious hypersensitivity reaction to semaglutide or excipients Current pregnancy or active breastfeeding Certain pancreatic conditions (evaluated at consultation) Not sure if you qualify
The primary endpoint for each trial was change in hemoglobin A1c (HbA1c) from baseline to the end of the trial
500 mg N-Acetyl L-Carnitine per capsule
Does Increased Heart Rate Offset the Cardiovascular Benefits
You might increase your units to compensate for perceived low potency, then receive a new, fully potent vial and accidentally overdose
Troy Watson and our team specialize in personalized weight loss programs that incorporate Semaglutide, a GLP-1 medication designed to help control appetite and regulate blood sugar